• Metacare CEO Lee Su Jin acquired 63,199 common shares through open-market purchases on Oct. 22–28, 2026.
• The holding represented a 0.29% stake as of Oct. 29.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metacare Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261029000083), on October 29, 2026, and is solely responsible for the information contained therein.